HONG KONG, Sept. 30, 2016 /PRNewswire/ -- Mason Financial Holdings Limited ("Mason Financial" or the "Company", stock code: 273:HK) today announced the signing of an agreement with Reproductive HealthCare ("RHC") and Victory Assisted Reproductive Technology Laboratory ("Victory"), fertility facilities founded by Hong Kong's Reproductive Medicine specialist Dr. Clement Ho Wing-chiu, to acquire a 55% stake in the amalgamated RHC-Victory holding company for a total consideration of HKD280 million. The holding company also has a 60% stake in a fertility center, under the "RHC" and "Victory" brands, located in Tsim Sha Tsui, Hong Kong. The investment in RHC and Victory and its well established in-vitro fertilization technology (also known as "IVF" or test tube baby technology) marks Mason Financial's entry into Hong Kong's premium medical services sector, further to its announcement earlier this month to establish an integrated global financial conglomerate. Mason intends to make further investments in Hong Kong and international premier medical services providers to capitalize on the growing "mother-infant-and-child" demographic demand in Greater China.
"We are pleased to enter into this strategic partnership with Dr. Ho and his team of medical specialists and embryologists," said Mr. Alex Ko, Joint Chairman and CEO of Mason Financial. "RHC is one of Hong Kong's largest private medical group practices providing infertility, prenatal diagnostics, urology, obstetrics and gynaecology services. We believe that the increasing demand for reproductive healthcare services in the local market, as well as the anticipated demand for quality in-vitro fertilization treatment from Mainland China market due to the recently announced two-child policy, will translate into immense growth opportunity for RHC and Victory. We look forward to working closely with Dr. Ho and his team in developing RHC into a premium medical services group servicing demand from the Greater China region."
Mason Financial will continue to focus on investments in sectors related to the demographic of mother-infant-and-child, particularly in the medical services industry. Backed by the Company's comprehensive financial services capabilities, and drawing the collective experience in investment banking and private equity from its professional management team, the Company is also planning for bespoke financial products and services for the healthcare industry, as well as a healthcare-focused private equity fund to create a synergistic mechanism where the financial and medical sector can complement and empower each other.
"In addition, following the introduction of our strategic investor, Mr. Hui Wing Mau, JP, who is the founder and largest shareholder of Shimao Group, the partnership will not be limited to the equity level, but will also extend to the financial and medical services sectors," Mr. Joel Chang, Group COO of Mason Financial added. "The Company will actively explore partnership opportunities between the Company's business activities (both in the domain of financial services and medical services) and Shimao's to meet Mainland China's robust demand for value added services (including quality medical services in Hong Kong)."
"Our partnership with Dr. Ho also illustrates Mason's investment strategy to target successful businesses with the profile of strong growth potential from favorable demographic/lifestyle demand and regional expansion opportunities at the macro level; and attributes such as strong brand and market share, very high quality management and human resources, a skill-based and asset light business model, high and sustainable margins, strong cashflow, and clean balance sheet at the company level. Our modus operandi is one of partnership with the management, and creates a win-win scenario and significant value for all stakeholders."
"I would like to express my gratitude to Mason Financial in facilitating the successful merger of RHC and Victory," said Dr. Clement Ho Wing-chiu, a Reproductive Medicine Specialist in Hong Kong and the founder of both RHC and Victory. "We look forward to closer cooperation with Mason Financial in the near future as we continue to grow our medical specialist team through our established programme of nurturing professional talents to further expand RHC. We will build capacity to cater for the increasing demand for reproductive medical services from Hong Kong and Mainland China, and offer our services to more people in Hong Kong and the rest of the Asia Pacific region."
Upon completion of the transaction, Mason Financial, Dr. Ho and Ms. Pang Yee Man, Ophelia will have stakes of 55%, 34% and 11%, respectively, in the RHC-Victory holding company.
About Mason Financial Holdings Limited
Mason Financial Holdings Limited (273.HK), through its various subsidiaries, is principally engaged in dealing in securities, futures brokerage, bullion trading services, provision of securities margin financing, investment and corporate finance advisory, money lending and investment holding. In November 2015, the Company fully acquired from Guoco Group (00053.HK) Guoco Capital Limited, Guoco Capital Futures Limited and Guoco Capital Bullion Limited, which were subsequently renamed Mason Securities Limited, Mason Futures Limited and Mason Bullion Limited, respectively. Pursuing strategies such as mergers and acquisitions and strategic alliances, Mason Financial is set to reposition itself to become a competitive global financial conglomerate with strong performance.
For inquiries, please contact Hill+Knowlton Strategies
| Ms. Shirley Lo |
Ms. Renee Chen |
| Tel: (852) 2894-6214 |
Tel: (852) 2894 6232 |
| Email: shirley.lo@hkstrategies.com |
Email: renee.chen@hkstrategies.com |
Photo - http://photos.prnasia.com/prnh/20160930/8521606251-a
Photo - http://photos.prnasia.com/prnh/20160930/8521606251-b
